EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
EXPAREL™, an investigational drug product, is a new formulation of a local anesthetic
(numbing medicine) that is designed to be longer acting than the currently-available local
anesthetics. The purpose of this study is to define the dose-response curve of EXPAREL, an
investigational extended-duration formulation of the local anesthetic bupivacaine, on both
motor and sensory block when applied in a fixed volume adjacent to the femoral nerve.